Koen holds a PhD in molecular biology from Yale University, where he focused on developing bioengineering strategies to improve pharmacokinetics of biologics.

Prior to joining as a Associate Director of the Blavatnik Fund for Innovation, he supported various Biotech and Medtech technologies as a Blavatnik Fellow. He also worked as a project leader at The Boston Consulting Group (BCG), where he gained experience working with senior leaders in large- and medium-sized pharmaceutical and medtech companies on topics ranging from R&D strategy, manufacturing optimization and commercial go-to-market strategies.